To the Editor: We believe that an important myositis-associated autoantibody, which could be of interest in the differential diagnosis, was overlooked by Drs. Korn and Mauiyyedi in their discussion of ...
Please provide your email address to receive an email when new articles are posted on . Autoimmune diseases may be easier to treat than cancers using cell therapy. Studies continue to examine its use ...
– 7 of 8 myositis patients achieved clinically meaningful TIS responses after discontinuation of all immunomodulators, while off or actively tapering steroids; responses were sustained throughout the ...
Cabaletta Bio, Inc. announced promising results from its ongoing RESET clinical trials for its investigational therapy rese-cel, focusing on autoimmune diseases. In the trials, notable outcomes ...
EXTENSIVE clinical data have been accumulated during recent years that support the view that scleroderma is a systemic disease. In addition to cutaneous involvement, which remains the cardinal ...
The committee will review select conditions related to the immune system and address diagnosis, treatment, and prognosis of those conditions. The select conditions should include but may not be ...
What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback